Antagonists of the chemotactic and inflammatory lipoxygenase product leukotriene B4 (LTB4) have been potential drug development targets for several years.1,2 The tetrazole LY255283 is a competitive antagonist of the BLT2 receptor. It displaces radiolabeled LTB4 from guinea pig lung membrane, with an IC50 of about 100 nM.3 LY255283 exhibits IC50 values of ~950 nM and >10 µM at human recombinant BLT2 and BLT1 receptors, respectively.4 LY255283 inhibits eosinophil chemotaxis by 80% at a concentration of 10 µM, and inhibits the binding of radiolabeled LTB4 to eosinophil membranes with an IC50 of 260 nM.1
1
Richards, I.M., Sun, F.F., Taylor, B.M., et al. Contribution of leukotriene B4 to airway inflammation and the effect of antagonists. Ann N Y Acad Sci629274-287(1991).
2
Taylor, B.M., Crittenden, N.J., Bruden, M.N., et al. Biological activity of leukotriene B4 analogs: Inhibition of guinea pig eosinophil migration in vitro by 2,6-disubstituted pyridine analogs U-75,302 and U-75,485. Prostaglandins42211-224(1991).
3
Silbaugh, S.A., Stengel, P.W., Cockerham, S.L., et al. Pulmonary actions of LY255283, a leukotriene B4 receptor antagonist. Eur J Pharmacol22357-64(1992).
4
Yokomizo, T., Kato, K., Hagiya, H., et al. Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. J Biol Chem276(15)12454-12459(2001).
Richards, I.M., Sun, F.F., Taylor, B.M., et al. Contribution of leukotriene B4 to airway inflammation and the effect of antagonists. Ann N Y Acad Sci629274-287(1991).
Taylor, B.M., Crittenden, N.J., Bruden, M.N., et al. Biological activity of leukotriene B4 analogs: Inhibition of guinea pig eosinophil migration in vitro by 2,6-disubstituted pyridine analogs U-75,302 and U-75,485. Prostaglandins42211-224(1991).
Yokomizo, T., Kato, K., Hagiya, H., et al. Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. J Biol Chem276(15)12454-12459(2001).
Silbaugh, S.A., Stengel, P.W., Cockerham, S.L., et al. Pulmonary actions of LY255283, a leukotriene B4 receptor antagonist. Eur J Pharmacol22357-64(1992).